IP Verse

Crystal Form Of Gsk1278863 And Preparation Method And Pharmaceutical Use Thereof - EP3682884

The patent EP3682884 was granted to Crystal Pharmaceutical Suzhou on Apr 24, 2024. The application was originally filed on Mar 13, 2018 under application number EP18857375A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3682884

CRYSTAL PHARMACEUTICAL SUZHOU
Application Number
EP18857375A
Filing Date
Mar 13, 2018
Status
Granted And Under Opposition
Mar 22, 2024
Grant Date
Apr 24, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ZBM PATENTSJan 24, 2025ZBM PATENTS ZEAADMISSIBLE

Patent Citations (4) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONCN101505752
INTERNATIONAL-SEARCH-REPORTCN101505752
OPPOSITIONWO2007150011
SEARCHWO2007150011

Non-Patent Literature (NPL) Citations (9) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "Safety data sheet of glacial acetic acid", Sigma-Aldrich, (20250121), pages 1 - 2, Sigma-Aldrich, URL: https://www.sigmaaldrich.com/GB/en/sds/sigald/a6283?userType=anonymous, XP093258610-
OPPOSITION- D02: Declaration of Dr Minhua Chen filed by the patentee during examination together with the reply to the European Search Opinion dated 04.05.2021-
OPPOSITION- D04: Reproduction of Example 18 Method 2 of WO2007150011 related to the preparation of daprodustat and characterization of the crystalline form obtained-
OPPOSITION- D07: Comprehensive crystal form screening GSK1278863A submitted by the patentee to the Japanese Patent Office on 11.07.2022 during examination of the Japanese patent application JP2020533396. Downloaded from https://www.j-platpat.inpit.go.jp/s0100-
OPPOSITION- D08: Educational guide of the Minnesota State University Moorhead related to recrystallisation techniques. Retrieved from https://web.mnstate.edu/jasperse/Chem355/Recrystallization-1.pdf-
OPPOSITION- D09: Educational guide of the University of Pittsburgh related to recrystallisation techniques. Retrieved from https://sites.pitt.edu/~bandik/organicweb/recrystallization.html-
OPPOSITION- D11 - Reproductions of Example 18 Method 2 of WO2007150011 related to the preparation of daprodustat and characterization of the crystalline form obtained-
OPPOSITION- Stephen Byrn et al, "Pharmaceutical Solids: A strategic Approach to Regulatory Considerations", Pharmaceutical Research, Springer Berlin Heidelberg, Berlin/Heidelberg, Berlin/Heidelberg, (19950701), vol. 12, no. 07, doi:10.1023/A:1016241927429, ISSN 0724-8741, pages 945 - 954, XP000996386
OPPOSITION- Cruz-Cabeza Aurora J., Reutzel-Edens Susan M., Bernstein Joel, "Facts and fictions about polymorphism", Chemical Society Reviews, Royal Society of Chemistry, UK, UK , (20151201), vol. 44, no. 23, doi:10.1039/C5CS00227C, ISSN 0306-0012, pages 8619 - 8635, XP093296423

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents